Hypertrophic cardiomyopathy with moderate septal thickness and mitral regurgitation: long-term surgical results

Elisabetta Lapenna1, Teodora Nisi1, Davide Carino1

  • 1Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.

Insights

In hypertrophic obstructive cardiomyopathy (HOCM) patients, myectomy alone may offer better outcomes than mitral valve surgery, despite a higher rate of residual mitral regurgitation. This suggests a tailored approach based on septal thickness is crucial for managing HOCM.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Devices

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) presents challenges in managing left ventricle outflow tract (LVOT) obstruction and mitral regurgitation (MR).
  • Surgical strategies aim to relieve obstruction and improve symptoms, but long-term outcomes vary.

Purpose of the Study:

  • To compare the long-term outcomes of septal myectomy alone versus mitral valve (MV) surgery with or without myectomy in HOCM patients.
  • To evaluate the effectiveness of different surgical interventions for moderate septal thickness and systolic anterior motion (SAM)-related MR.

Main Methods:

  • A retrospective study of 76 HOCM patients with specific septal thickness and MR severity.
  • Patients underwent either septal myectomy alone (54%) or MV surgery ± myectomy (46%).
  • Outcomes including survival, cardiac death, and MR recurrence were assessed over a median follow-up of 8 years.

Main Results:

  • No hospital deaths or ventricular septal defects occurred.
  • MV surgery ± myectomy group had longer procedural times and higher low output syndrome incidence.
  • Overall survival showed no significant difference, but myectomy alone trended towards lower cardiac mortality and had significantly lower MR recurrence at 9 years.

Conclusions:

  • Septal myectomy alone may be associated with a better postoperative course and lower cardiac mortality in selected HOCM patients.
  • While myectomy alone may lead to higher residual MR, addressing MV apparatus abnormalities might be necessary in some cases for durable relief.
  • Surgical strategy should be individualized based on septal hypertrophy and MV involvement for optimal HOCM management.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
169
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
125
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
122
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
109
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
85
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
121